FierceBiotech· FierceBiotech·· 4 小时前AI 评分30
CBER主任Mikhail谈重建稳定与士气
After a turbulent period at the FDA, CBER Director Karim Mikhail tells Fierce he's focused on restoring stability, rebuilding morale and ...
AI 导读
经历FDA动荡期后，CBER主任Karim Mikhail向Fierce表示，他正专注于恢复稳定、重建士气并重新思考罕见病监管，并称自己不会回避。
阅读原文
来源：FierceBiotech · x.com